Identifying the Best Flow Setting Strategy for High-Flow Nasal Cannula
Optimizing High-flow Nasal Cannula Settings: Comparing Different Flow Approaches and Exploring Physiological Phenotyping With End-expiratory Lung Volume, Peak Tidal Inspiratory Flow and Oxygen Demand
1 other identifier
interventional
480
1 country
1
Brief Summary
The goal of this randomized trial is to compare four different flow-setting approaches for post-extubation use of high-flow nasal cannula (HFNC). Selecting the appropriate flow rate when initiating HFNC oxygen therapy is both crucial and challenging for clinicians, as the physiological benefits of HFNC depend significantly on the flow rate. To date, there are no guidelines or consensus on flow-rate setting and weaning for HFNC oxygen therapy. The investigators hypothesized that physiological marker-guided flow setting using peak tidal inspiratory flow (PTIF) or PaO₂/FiO₂ ratios lead to better extubation outcomes as compared to empirical flow setting of 40 L/min or 60 L/min. Participants will be randomly assigned to one of four study groups with different flow setting strategies summarized as follows: (1) Setting flow at 40 L/min, (2) Setting flow at 5 L/min above the peak tidal inspiratory flow, up to a maximum of 60 L/min. (3) Setting flow according to P/F ratio prior to extubation. Flow will be set at 60, 50 40 L/min if P/F ratio \<250 mmHg, 250-300 mmHg and \>300 mmHg, respectively. (4) Setting flow at 60 L/min.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2025
CompletedStudy Start
First participant enrolled
June 5, 2025
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
June 6, 2025
May 1, 2025
3.1 years
May 18, 2025
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
A composite outcome of noninvasive ventilation (NIV) use or reintubation within five days after extubation
A single global test of significance to compare between-group difference in the composite outcome
5 days
Secondary Outcomes (6)
Proportion of reintubation within five days after extubation
5 days
Proportion of NIV use within five days after extubation
5 days
28-day mortality
28 days
Change in PaO2/FiO2 ratio between 0 and 24th hour
24 hours
Change in arterial CO2 level (mmHg) between 0 and 24th hour
24 hours
- +1 more secondary outcomes
Study Arms (4)
Flow of 40L/min
ACTIVE COMPARATORSetting HFNC flow at 40 L/min
Peak tidal inspiratory flow (PTIF) guided
EXPERIMENTALSetting HFNC flow at 5 L/min above the peak tidal inspiratory flow (PTIF), up to a maximum of 60 L/min.
PaO2/FiO2 ratio guided
EXPERIMENTALSetting HFNC flow according to P/F ratio prior to extubation. Flow will be set at 60, 50 40 L/min if P/F ratio \<250 mmHg, 250-300 mmHg and \>300 mmHg, respectively.
Flow of 60L/min
EXPERIMENTALSetting HFNC flow at 60 L/min
Interventions
Setting HFNC flow at 5 L/min above the peak tidal inspiratory flow (PTIF), up to a maximum of 60 L/min.
Setting HFNC flow according to P/F ratio prior to extubation. Flow will be set at 60, 50 40 L/min if P/F ratio \<250 mmHg, 250-300 mmHg and \>300 mmHg, respectively.
Eligibility Criteria
You may qualify if:
- Intubated and receiving mechanical ventilation for more than 24 hours
- Ready for planned extubation after passing a spontaneous breathing trial
- PaO2/FiO2 \<350 mmHg on the day of extubation
You may not qualify if:
- Age \<18 years
- On do-not-reintubate code
- Pregnant women
- Having tracheostomies
- Infeasibility of using HFNC
- Planning to use preventive NIV after extubation by the primary care team
- Life expectancy less than one month
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Sheng-Yuan Ruan, MD
Study Record Dates
First Submitted
May 18, 2025
First Posted
June 6, 2025
Study Start
June 5, 2025
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
June 6, 2025
Record last verified: 2025-05